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A B S T R A C T
Osteoarthritis (OA) is a prevalent disease of most mammalian species and is a signiﬁcant cause of welfare
and economic morbidity in affected individuals and populations. In vitro models of osteoarthritis are vital
to advance research into the causes of the disease, and the subsequent design and testing of potential
therapeutics. However, a plethora of in vitro models have been used by researchers but with no con-
sensus on the most appropriate model. Models attempt to mimic factors and conditions which initiate
OA, or dissect the pathways active in the disease. Underlying uncertainty as to the cause of OA and the
different attributes of isolated cells and tissues used mean that similar models may produce differing
results and can differ from the naturally occurring disease.
This review article assesses a selection of the in vitro models currently used in OA research, and con-
siders the merits of each. Particular focus is placed on the more prevalent cytokine stimulation and load-
basedmodels. A brief review of themechanism of thesemodels is given, with their relevance to the naturally
occurring disease. Most in vitro models have used supraphysiological loads or cytokine concentrations
(compared with the natural disease) in order to impart a timely response from the cells or tissue as-
sessed. Whilst models inducing OA-like pathology with a single stimulus can answer important biological
questions about the behaviour of cells and tissues, the development of combinatorial models encom-
passing different physiological and molecular aspects of the disease should more accurately reﬂect the
pathogenesis of the naturally occurring disease.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Osteoarthritis (OA) is the most common form of arthritis and is
one of the leading causes of disability worldwide. Most mamma-
lian populations are affected, including humans and domesticated
animal species, including sheep (Vandeweerd et al., 2013), horses
(Ireland et al., 2013), cats (Clarke et al., 2005) and dogs (Clements
et al., 2009). Estimates in human populations suggest that 9.6% of
men and 18% of women over the age of 60 years have symptom-
atic OA (Woolf and Pﬂeger, 2010). In 2006–2007 in the United
Kingdom, 94% of hip and 97% of knee replacements were carried
out for relief of OA. Consequently, OA is a major concern, particu-
larly in ageing populations (Nguyen et al., 2011).
Symptoms of OAmost commonly include pain, swelling and stiff-
ness in the affected joint, resulting from the degradation of articular
cartilage (Madry et al., 2012), changes in the composition of the sub-
chondral bone (Sniekers et al., 2008; Saito et al., 2012) and synovitis
(Goldhammer et al., 2010). Historically, OA was primarily ob-
served in elderly people, which led to the idea that OA was a ‘wear-
and-tear’ type disease (Berenbaum, 2013). However, this idea is now
less favoured because younger patients often display symptoms of
OA secondary to injuries or because of a genetic predisposition to
the disease (Da Silva et al., 2009).
OA is a multifactorial disorder and no single aetiological mech-
anism has been found common to all forms of the disease (Iliopoulos
et al., 2007). Large genetic studies have identiﬁed numerous genetic
risks for OA (Reynard and Loughlin, 2013), although the odds ratios
for most single nucleotide polymorphism (SNP) associations are low,
and rarely do they apply to more than one form of the disease. The
mechanisms which underpin genetic risks are often unidentiﬁed,
and in vitro models are critical if we are to expand our understand-
ing of their role in disease progression.
Both in vivo and in vitro models of OA have been used in the
past (Goldring et al., 2008; Fang and Beier, 2014; Grenier et al., 2014).
Whilst models can be broadly grouped according to the primary
mechanism by which the catabolic process is stimulated, each with
its own strengths and weaknesses (Table 1), subtle variations mean
that an almost inﬁnite number of variations exist for a single model
(Benam et al., 2015). Similarly, whilst in vivo models may give the
most accurate reﬂection of the naturally-occurring whole-joint
disease, the ease of manipulating an in vitro system, as well as a
shift towards the 3R philosophy of reﬁning, reducing and replacing
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the use of animals in animal science (Madden et al., 2012) makes
in vitromodelling of the disease desirable. The observation that spon-
taneous OA in domestic animals has a similar pathogenesis to that
observed in humans (Clements et al., 2006), and the availability of
naturally-occurring, early-stage diseased tissue, for example at
slaughter in food animal species or following a veterinary surgical
intervention in companion animals (Clements et al., 2009) make do-
mestic animals an important source of clinical material for such
models.
Additionally, models of OA offer the opportunity to study early
features of the development of the disease, prior to the develop-
ment of a fulminant catabolic process, which have been diﬃcult to
dissect because of the lack of available tissue from early disease and
the limitedmolecular changes associated with it (Aigner et al., 2006).
No consensus on the most appropriate model for the representa-
tion of particular features of OA has been made, as each model has
its ownmechanisms for the induction of a general catabolic process.
Furthermore, the molecular phenotypes of different forms of OA also
show distinct differences (Xu et al., 2012), and such subtleties can
be considered when designing models of OA rather than ignoring
them when using more general in vitro models.
The relevance of in vitro models to clinical disease always needs
to be interpreted with caution. For example, numerous publica-
tions report the chondroprotective effects of glucosamine and
chondroitin sulphate in in vitro models (Dechant et al., 2005; Chan
et al., 2007), but clinical trials have failed to show such effects in
vivo (Sawitzke et al., 2010; Wandel et al., 2010). Whilst some effects
of the differences can be ascribed to delivery, complexity, dura-
tion and variation of the phenotype, ultimately in vitromodels should
be designed to better reﬂect the natural in vivo disease. This par-
ticularly applies to the disease state, where almost all models are
designed to replicate the symptoms of end-stage OA, with little or
no regard to the early disease, where chondroprotection is likely
to yield greater beneﬁts.
This review summarises the two most commonly used in vitro
models of OA, namely, cytokine-based models and load-based
models, and then discusses their various merits and how they reﬂect
the naturally-occurring processes.
Cytokine induction of OA-like processes
Classic research on OA has focused on cartilage, but other tissues
such as bone, synovium, ligament, infrapatellar fat (Maccoux et al.,
2007) and periarticular muscles (Geyer et al., 2009) are also in-
volved (Fig. 1). The changes seen in these tissues are attributed to
diffusible factors, including proteolytic enzymes, such as matrix
metalloproteinases (MMPs) and members of the ‘a disintegrin and
metalloproteinase with thrombospondin-motif’ (ADAMTS) family
that are present in the joint environment during the disease (Little
et al., 2005; Clements et al., 2006).
Cytokines in OA
During OA, synoviocytes, mononuclear cells or chondrocytes may
increase their expression of catabolic proteins (Fernandes et al., 2002)
following stimuli such as cytokine or chemokine exposure, includ-
ing interleukin (IL)-1β and tumour necrosis factor (TNF)-α, which
are present in the joint following synovial inﬂammation (Sohn et al.,
2012). Pro-inﬂammatory cytokines make ideal candidates for the
induction of OA-like biological changes in articular cells or tissues
in culture, in which temporal and concentration effects can be
explored.
Models of OA where cytokines are the primary method of in-
duction are very common and are generally well understood. The
model is usually inexpensive and is very easily manipulated. The
ability to expand cells in vitro also means that many replicates are
possible, allowing multiple hypotheses to be tested from single
sources of tissue. Nevertheless, cells in culture (particularly
chondrocytes) are prone to dedifferentiate to ﬁbroblasts after only
a small number of passages (Caron et al., 2012; Minegishi et al.,
2013), and isolating cells from their matrix removes possible matrix-
effects. Additionally, inter-tissue crosstalk is diﬃcult to characterise
in vitro and both time- and concentration-dependent effects are not
well understood (Table 1).
Evidence for a role of IL-1β in OA is well established, and it has
been used as a potential therapeutic target, for example through
the design of vectors activated by IL-1 that protect against its cata-
bolic effect (Campbell et al., 2005) or through the antagonism of the
IL-1 receptor (IL-1R) (Chevalier et al., 2009). Exposure to IL-1β stimu-
lates chondrocytes and synovial cells to produce catabolic proteases
(Maccoux et al., 2007), with apocrine signalling further enhancing
MMP release and the resulting degradative cascade. The catabolic
response can be blocked by the inhibition of IL-1β through antag-
onism with the IL1-R antagonist (IL-1Ra) (Bujak and Frangogiannis,
2009).
Inﬂammatory molecules produced by chondrocytes in re-
sponse to IL-1β include prostaglandin (PG)E2, cyclooxygenase (COX)-
2, IL-6, IL-8 and leukaemia inhibitory factor (LIF). IL-1β also leads
to the accumulation of reactive oxygen species, through expression
of inducible nitric oxide synthase (iNOS) by the transcription factor
Table 1
Advantages and disadvantages of some of the most commonly used in vitro models.
Model type Variables that can be applied Advantages Disadvantages Examples
Monolayer
culture
Cytokine stimulation, osmotic
pressure
Allows expansion of cellular resource
from a single sample, investigation of
distinct pathways in isolation
Altered phenotype of isolated cells due
to isolation from tissue and absence of
normal extracellular matrix
(Novakofski et al., 2012; Sylvester
et al., 2012)
Co-culture Cytokine stimulation, osmotic
pressure
Considers cross-talk between cell
types
Altered phenotype of isolated cells
Different cell types require different
culture conditions, or compromise if
culture together
(Lin et al., 2010; Beekhuizen et al.,
2011; Vazquez et al., 2014)
3D-culture Cytokine stimulation, osmotic
pressure, physical injury and
loading regimens
Affords structure and force to sensitive
cells
Magnitude of force is scaffold
dependent and may not reﬂect that of
the normal tissue
Isolation and expansion of cell types
ﬁrst
(Mizuno and Ogawa, 2011;
Bougault et al., 2012;
Pingguan-Murphy and Nawi, 2012)
Explant Cytokine stimulation, osmotic
pressure, physical injury and
loading regimens.
Inexpensive, easily produced, cells
maintained in normal extracellular
matrix
Cell death at cut edge of tissue, few
replicates available from same source,
more than one tissue type may be
required to maintain viability, physical
attributes may change in culture
(Fitzgerald et al., 2004; Bush et al.,
2005; Jeffrey and Aspden, 2006;
Gabriel et al., 2010)
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nuclear factor kappa B (NF-κB), ultimately leading to apoptosis
(Fig. 2a). This mechanism can also be accelerated by IL-1β-mediated
damage to mitochondrial DNA, leading to a further release of re-
active oxygen species and enhancing apoptosis (Loeser, 2011).
IL-1 plays a role in bone pathophysiology relevant to OA, par-
ticularly IL-1α which is also known as osteoclast activating factor
(Lee et al., 2010). In bone, there is an increase in the activity of PGE2
in osteoblasts and stromal cells, as well as an increase in the ex-
pression of receptor activator of NF-κB Ligand (RANKL). RANKL is
critically involved in the activation, maturation and survival of os-
teoclasts (Tanaka et al., 2005). IL-1 has also been shown to induce
multinucleation of osteoclasts, thus potentiating the function of the
cells. In vivo, when adult rats were injected with amoderate amount
of IL-1β (1 μg/kg bodyweight), an increase in serum and urinary Ca2+
Fig. 1. Healthy and diseased synovial joints showing the changes in the entire joint organ. Bone weakness and wearing has been reported, as well as synovial thickening
and swelling, subchondral bone thickening, osteophyte formation and cartilage degradation. In addition, tendons can become weak and inﬂamed, and ligaments can become
lax.
Fig. 2. Mechanistic pathways of in vitro models of osteoarthritis (OA). Both cytokines (a) and injurious loading (b) combine to cause the typical OA-like phenotype, showing
apoptosis of cells, tissue degradation and inﬂammatory gene expression. In these cases, feedback loops occur either through inﬂammation, causing further cytokine stim-
ulation, or abnormal loading, caused by tissue degradation. However, normal homeostatic loading is vital to tissue health, and works through similar pathways, as shown
by the green line in (c), leading to tissue growth. MAPK, mitogen-activated protein-kinase; JNK, c-Jun N-terminal kinase; AP-1, activator protein-1; NFκB, nuclear factor
kappa B; COX2, cyclooxygenase-2; PGE2, prostaglandin-E2; MMP, matrix metalloproteinase; ADAMTS, a distintegrin and metalloproteinase with a thrombospondin motif;
ROS, reactive oxygen species.
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concentrationwas noted, as well as an increase in osteoclast number,
implying an increase in bone resorption (Nguyen et al., 1991).
TNF-α has also been used to induce OA-like changes in in vitro
experiments, because it is found in diseased synovial ﬂuid (Horiuchi
et al., 1999; Fujita et al., 2005), and is able to induce catabolism and
inhibit anabolic pathways in joint tissues and cartilage cells (Liacini
et al., 2003). While IL-1β and TNF-α are the most commonly used
cytokines in modelling OA, other cytokines may also play impor-
tant roles. Concentrations of IL-6, IL-8, vascular endothelial growth
factor (VEGF) and monocyte chemoattractant protein-1 (MCP-1) are
all increased in the synovial ﬂuid of OA joints (Sohn et al., 2012).
Osteoclasts are recruited by IL-6 and thus this cytokine may be an
important modulator of the bone remodelling observed in OA
(Silfverswärd et al., 2004). However, inmodel designs, these cytokines
are rarely considered, possibly because they are characterised as
chondrocyte-derived and thus they can be induced by other
cytokines, such as IL-1β or TNF-α (Bunning et al., 1990). Using
cytokines in combination may allow for the induction of OA-like
cell and tissue responses that more closely replicate the natural
disease, particularly in lieu of synovial effects in the model design.
In vivo determination of cytokine concentrations
Cytokine-based models use a wide variety of concentrations and
durations of cytokine stimulation, namely those which produce a
measurable downstream effect, rather than a concentration that re-
ﬂects that in naturally occurring disease. Furthermore, OA is a slowly-
progressing disease and relatively small increases in cytokine
concentrations have been identiﬁed in naturally-affected joints.
When OA synovial ﬂuid is assayed, the quantities of IL-1 (<2 ng/
mL) and TNF (3 ng/mL) are highly variable between experiments,
but are low in comparison with those used to exert an effect in vitro
(Table 2). The variation in physiological concentrations is evident
and may be the result of several factors, including the method used
to quantify the cytokines, or the phenotype of the disease. In con-
trast, the concentrations used in models are typically much higher
at up to 100 ng/mL of IL-1β (Macrory et al., 2009), and up to 50 ng/
mL of TNF-α (Gabriel et al., 2010).
Explant-based models of cytokine stimulation
Explant-based models are simple and easy to produce, and have
the major advantage that they can be used to examine the re-
sponse of cells in their natural extracellular matrix; once removed
from their extracellular matrix, the cell phenotype is altered (Zien
et al., 2001). Using explanted tissue also allows features such as
matrix degradation to be observed. However, the use of tissue ex-
plants creates new problems; for example, cells at the explant edge
die (Hunziker and Quinn, 2003; Gilbert et al., 2009), there are limi-
tations to the number of samples which can be obtained from the
same source and more than one tissue might be required to main-
tain viability (Amin et al., 2009).
Cartilage is highly sensitive to TNF-α and physiologically rele-
vant concentrations as low as 0.25 ng/mL (Westacott et al., 1990)
are suﬃcient to increase the release of glycosaminoglycans (GAGs)
from OA cartilage (human) when compared with healthy cartilage
in a 14 day period (Westacott et al., 2000). Species-speciﬁc differ-
ences may exist in the stimulation required to elicit a particular
response (such as GAG release); thus, GAG release from feline car-
tilage explants requires stimulation with both recombinant human
IL-1β and oncostatin-M (OSM) in combination (Gabriel et al., 2010),
although a feline-speciﬁc stimulus may have elicited a different
response.
A possible autocrine network has been suggested because both
IL-β and TNF-α show strong positive protein staining in the super-
ﬁcial zone of cartilage, as well as in the synovial ﬂuid in late-stage
OA. Meanwhile, deep zone cells only demonstrate marginal stain-
ing in the most severe cases (Tetlow et al., 2001), illustrating the
differential responses of chondrocytes in disease. Notably, the early
stages of disease rarely demonstrate any chondrocyte expression
of cytokines, implying that any inﬂammatory cytokines present in
the joint at the early stage of the disease are most likely to be sy-
novial in origin (Tetlow et al., 2001).
Chondrocyte culture-based cytokine models
The choice of whether to use a monolayer, a cell scaffold or intact
tissue will inﬂuence the cells’ response to the cytokine stimulus
applied. The sensitivity of chondrocytes to their molecular and
loading environment dictates that, ideally, they should not be iso-
lated from their matrix or, if they are, the matrix in which they are
embedded should closely match the behaviour of normal, healthy
tissue. However, the low cellularity of cartilage necessitates the
demand for large explants, thereby reducing the number of repli-
cates which can be obtained from a single tissue source. Monolayer
cultures allow the expansion of the cellular resource, although this
is ﬁnite for tissues such as cartilage (Nicholson et al., 2007), since
the cell phenotype changes in monolayer culture (Zien et al., 2001).
The ease of using chondrocytes in monolayer, combined with
their rapid response to cytokine stimulation, has resulted in this
being the most widely used model. Numerous models that use
cytokines added to cell or tissue culture medium have been shown
to produce OA-like responses in chondrocytes in monolayer cul-
tures, such as a decrease in the expression of type 2 collagen and
aggrecan, and an increase in the expression of MMP-13, across mul-
tiple species (Miyaki et al., 2009; Novakofski et al., 2012; Yang et al.,
2014).
Alternatively, stimulating chondrocytes with the synovial ﬂuid
from OA patients (Hoff et al., 2013), a more physiologically-relevant
stimulus, produces similar results, including the expression of the
pro-inﬂammatory cytokines IL-6, IL-8, IFN-γ, MCP-1, granulocyte-
colony stimulating factor (G-CSF) and VEGF. However, this method
of stimulation is also limited by the imprecise understanding of the
relative contribution of different mediators which are driving ca-
tabolism in this model, and the lack of repeatability because of the
limited synovial ﬂuid volume that can be obtained from a single
source.
Co-culture-based cytokine models
Recognising that OA is a disease that affects and involves the in-
teraction between multiple tissues are co-culture experiments that
permit the study of these interactions in vitro. Cytokine or osmotic
pressure stimuli can be easily applied to co-culture models, al-
though the tissues might require different culture conditions,
necessitating some compromise on the culture conditions usedwhen
cultured together. The co-culture of synovial membrane with
chondrocytes is one method by which the complexity of the pro-
Table 2
Osteoarthritic (OA) synovial ﬂuid interleukin (IL)-1β and tumour necrosis factor
(TNF)-α concentrations in vivo.
Condition Cytokine
IL-1β TNF-α
Control (human) (Kahle et al., 1992) <20 pg/mL 2890 pg/mL
Control (canine) (Fujita et al., 2005) 490 pg/mL 105.3 pg/mL
OA (human) (Kahle et al., 1992) 21 pg/mL 80 pg/mL
OA – Hip dysplasia (canine) (Fujita et al., 2005) 2010 pg/mL 600 pg/mL
OA – Mild (porcine) (McNulty et al., 2013) 109 pg/mL –
OA – Moderate (porcine) (McNulty et al., 2013) 122 pg/mL –
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inﬂammatory cascade can be reproduced in vitro, because synovium
is the primary source of these mediators (Ushiyama et al., 2003).
Co-culturing synovium from OA patients with healthy carti-
lage explants produces an increase in the expression of IL-1, IL-4,
IL-7, IL-8, IL-10, IL-13 and osteoprotegerin (OPG), similar to syno-
vial ﬂuid from OA joints, as well as reducing GAG production in the
cartilage (Beekhuizen et al., 2011). Whilst it may be desirable to use
synovium to model OA in vitro, this tissue is composed of two dif-
ferent, but interacting, cell types and shows highly variable lesion
patterns both across different OA joints, and within a single joint
with clinical OA (Rhodes et al., 2005; Goldhammer et al., 2010; Smith,
2011). Consequently, deconstructing the effects within the syno-
vial co-culture model is complex, although characterisation of the
factors responsible for the response will help to standardise across
experiments. The use of bone in co-culture experiments is also im-
portant, because it appears to have a role in maintaining the long-
term viability of chondrocytes in the superﬁcial zone of articular
cartilage (Amin et al., 2009).
Bone cytokine models
Evaluation of the response of bone to cytokine stimulation in
models of OA is scarce, which is unsurprising because it is diﬃ-
cult to ascertain the precise cytokine environment to which bone
cells are exposed to in OA. Most data on cytokine roles in bone focus
on the speciﬁc roles of TNF-α, IL-6 and IL-1 release during osteo-
cyte injury (Komori, 2013). Furthermore, generation of RANKL is
induced by IL-6 and IL-1, and mice lacking RANKL completely lack
osteoclasts (Kong et al., 1999). Osteoclasts driven to apoptosis release
soluble RANKL and conditionedmedia from these cells further induce
osteoclastogenesis (Al-Dujaili et al., 2011). Notably, bone plays a
larger role than previously considered in cartilage health and removal
of cartilage explants from the underlying bone tissue leads to a higher
percentage of cell death in chondrocytes than if chondrocytes were
left attached to the bone (Amin et al., 2009).
Mouse calvarial cultures incubated with IL-1 showed bone re-
sorption, demonstrating that cytokines act on cultured bone (Gowen
et al., 1983), and cultured osteoblasts actively synthesised NO in re-
sponse to IL-1α in a dose-dependent fashion, although IL-1β, TNF-α
and IFN-γ failed to elicit a response (Ake et al., 1994). Evidently,
cytokines play a role in bone turnover, and bone is responsive to
inﬂammatory stimuli. IL-1β has been shown to induce the release
of PGE2, MMP-3 and MMP-13 from osteoblasts (Pecchi et al., 2012),
although this can be inhibited with chondroitin sulphate.
Load-based models of inducing OA
Chondrocytes are sensitive to load, and must always be under
suﬃcient force to maintain extracellular matrix homeostasis, yet
below that which induces apoptosis or stimulates an inﬂammato-
ry cascadewithin the tissue (Henrotin et al., 2012). Subchondral bone
is also mechanosensing and responds in vivo by changing its thick-
ness and reducing its resorption when loading is increased (Murray
et al., 2001). Identifying the load thresholds that alter the balance
frommaintenance of homeostasis to injury is important to our un-
derstanding of the magnitude of a beneﬁcial or deleterious load.
Loadmodels are easilymanipulated and, as a result, high through-
put experiments can be performed. Signalling pathways associated
with mechanotransduction are becoming well understood
(Millward-Sadler and Salter, 2004; Mobasheri et al., 2005), allow-
ing better appreciation of the processes associated with this model.
Removing cells from their native matrix and embedding them into
an artiﬁcial scaffold alters, at least theoretically, the native signal-
ling network, and the force used in the experiment is innately
dependent on the ability of the scaffold to withstand that force.
Cell loading models require high cell numbers that might not
be available from some sources. Using entire tissues overcomes this
problem and allows cells to use natural cell-matrix interactions and
cross-tissue communication, as well as much greater forces. Con-
versely, native tissue experiments are limited to larger species and
lower numbers of replicates. Additionally, cells have been shown
to undergo substantial cell death at the cut edge (Huntley et al.,
2005a, 2005b), so distorting observations at these sites (Table 1).
In vivo determination of cartilage load
Several in vivo studies have attempted to determine the phys-
iological pressures experienced by articular cartilage during loading.
The pressure passing through the load-bearing region of a human
acetabular prosthesis has been determined to be approximately
3.5 MPa during locomotion (Hodge et al., 1989) and the articular
contact pressure of the human knee does not exceed 8 MPa, even
when the menisci have been removed (Fukubayashi and Kurosawa,
1980). Loads of a similar magnitude have been reported in both the
medial and lateral compartments of canine elbow joints, with mean
contact pressures between 3.0 and 4.0 MPa and peak pressures
between 6.6 and 9.1 MPa (Cuddy et al., 2012). These data suggest
that the articular loading experienced by different joints in differ-
ent species are physiologically comparable and concurs with
estimates of the articular cartilage compressive stress in different
mammalian species, which only vary within one order of magni-
tude from mice to cows (Simon, 1970).
Chondrocytes sense the loading of their environment through
integrin receptors (Bader et al., 2011). When activated, the integrins
stimulate stress pathways leading to cytoskeletal disruption and
release of inﬂammatory cytokines, such as IL-1β and TNF-α (Valhmu
et al., 1998; Durrant et al., 1999; Bader et al., 2011). Cytokine-
induced proteolytic enzyme release is mediated by nitric oxide, PGE2
and reactive oxygen species. The extracellular proteins cleaved by
the activated proteases are then capable of further induction of both
proinﬂammatory cytokines and matrix proteases, although the re-
ceptors activated by collagen fragments remain elusive (Klatt et al.,
2009).
The signalling pathways induced by static loading and cytokine
induction are similar and themechanism that governs both is similar
in bothmodels (Fig. 2b). However, the compression pathway appears
to be reliant on the magnitude and duration of the stress (Fanning
et al., 2003).
Explant based models of cartilage loading
The use of tissue explants, assessing the response of cells em-
bedded in the natural matrix, is the simplest method for assessing
the effects of load. Load is applied to tissue explants through various
methods, based on the variable in question. Most typically, ‘drop
towers’, in which a free weight is released from a predetermined
height onto the tissue, are used to impart a single impact load. This
is believed to replicate the development of ‘post-traumatic’ OA, which
occurs following an injurious articular load. Load can also be applied
in a cyclical manner with devices such as pneumatic or hydraulic
loading chambers.
Static loading can induce similar deleterious changes in carti-
lage explants when applied at an appropriate magnitude. For
example, a compressive strain of 50% applied to a cartilage explant
results in a decrease in the synthesis of collagen type II and
proteoglycans (Chen et al., 2001). Static compression of calf
patellofemoral cartilage to 25% or 50% strain for 24 h produces del-
eterious changes in cartilage metabolism, resulting in an increase
in expression of MMP3, 9 and 13mRNA and decrease in COL2A1 and
aggrecan (ACAN) within 1–2 h post loading (Fitzgerald et al., 2004).
IL-1 receptor activation and activation of the extracellular-signal
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related kinase 1/2 (ERK1/2), p38, mitogen-associated protein kinase
(MAPK) familymember pathways in a time-dependentmannermed-
itate these changes (Fanning et al., 2003).
A load equivalent to 1.5× bodyweight placed on a human knee
joint caused only 10% strain in the patellofemoral cartilage follow-
ing 10 min of static loading (Wong and Sah, 2010). Similarly, intact
human femoral head cartilage loaded to the equivalent of a single
leg stance (less than 2.3 × bodyweight) is subject to a strain of 33%
(Greaves et al., 2010). Consequently, the use of higher strains in in
vitro models exaggerates the maximal normal physiological load ex-
perienced by a joint in vivo, although this reﬂects the requirement
to induce an effect within a shorter time frame. Furthermore, the
elastic (Young’s) modulus varies across cartilage within a joint
(Shepherd and Seedhom, 1999), and thus the load required to induce
a speciﬁc strain, or strain produced from a speciﬁc load will also
differ across samples from the same joint.
In vitro studies have been used to determine the critical stress
thresholds of cartilage explants, in which apoptosis, collagen deg-
radation and nitrite accumulation are observed. Values range from
4.5 MPa for cyclic loading (six compressions to a ﬁnal strain of 30–
50%, held for 5min rested for 25min, Loening et al., 2000) to 15MPa
for a single impact load (Torzilli et al., 1999) for bovine cartilage,
although the results between experiments are highly variable.
Notably, bovine cartilage explants subjected to a 0.5 MPa cyclic
loading increase proteoglycan synthesis across various cycle lengths
(Parkkinen et al., 1992), supporting the hypothesis that moderate
loading is beneﬁcial to cartilage health.
Chondrocyte culture-based loading models
The response of cells to load can be dissected further by isolat-
ing cells in culture, embedding them in an artiﬁcial matrix and
compressing them using a bioreactor. This has the advantage of per-
mitting very precise changes in loading parameters, as it is highly
reproducible, as well as looking at the effects of different matrices
on the cellular response. However, a large caveat to such experi-
ments is that the cell response observed in vitro may not represent
that observed in vivo, where the interaction of the matrix is criti-
cal to the effect produced.
In vitro loading of isolated chondrocytes seeded in a
3-dimensional (3-D) culture (typically agarose) results in both an
increase in cell proliferation and proteoglycan synthesis when cy-
clically loaded at a physiological strain of 15% (Lee and Bader, 1997).
3-D culture also allows for the application of bi-axial cyclic loading
(direct compression or tension, and shear) (Pingguan-Murphy and
Nawi, 2012), and addresses the observation that, in vivo, several loads
may simultaneously impact on a joint during normal activity. When
subjected to biaxial loading (10% compressive strain with 1% sheer
strain) for two 12 h periods, separated by a 12 h resting period, both
cell proliferation and an increase in GAG production were ob-
served, demonstrating the importance of closely representing the
joint environment in in vitro experiments.
Cyclic loading of bovine chondrocyte-embedded calcium
polyphosphate scaffolds at 1 kPa and 1Hz for 30min activates Erk1/2
and c-Jun N-terminal kinase (JNK), as seen with static loading, and
causes an increase in activator protein-1 (AP-1) binding. This stim-
ulus induces MMP-3 and 13 mRNA expression and results in MMP-
13 mediated extracellular matrix (ECM) degradation. However,
following the loss of functional tissue, collagen type II and aggrecan
gene expression occurs after 12 h, and synthesis occurs by 24 h post
loading (Fig. 2c) (De Croos et al., 2006).
Co-culture based loading models
Co-culture methods have been used to explore the effect of
loading on articular tissues in parallel, although they are challenged
by the necessity to use different culture conditions for each tissue,
or to compromise the culture conditions. For example, alginate-
embedded chondrocytes cultured on a porous ﬁlter above
mechanically stretched osteoblasts becomemore hypertrophic during
stimulation of the osteoblasts. This change was most pronounced
when the osteoblasts were subjected to tensile loads, suggesting that
molecular ‘cross-talk’ occurs between the two cell types in re-
sponse to mechanical stress in bone (Lin et al., 2010).
Co-culture of OA osteoblasts with healthy alginate bead-
embedded chondrocytes results in a phenotypic shift to chondrocyte
hypertrophy and matrix mineralisation, which does not occur with
healthy osteoblasts stimulated with IL-1, IL-6 or OSM (Sanchez et al.,
2005). This demonstrates the limits of artiﬁcially stimulating cells
and the phenotypic differences of naturally-diseased cells, and high-
lights the need for better characterisation of the soluble factors
released by these cells, as well as better deﬁnition of the molecu-
lar stimulation required to induce the OA phenotype in healthy cells.
Bone loading models
Osteocytes are themajor mechanosensors of bone, although they
are rarely included in models of OA, because they are notoriously
diﬃcult to culture in vitro. Analysis of the osteocyte (in contrast to
osteoblast) response to compression has been hindered due to this
challenge (Kato et al., 1997). Osteocyte cell lines seeded into type
I collagen gels layered with osteoblasts on their surface respond to
mechanical loading, with co-cultured constructs increasing type I
collagen expression with loading, and osteocyte embedded gels ex-
pressing PGE2 after mechanical stimulation (Vazquez et al., 2014).
Relevance of load: From in vivo to in vitro models
The validity of a loading model depends, at least to some extent,
on its relationship with the natural environment of the joint and
its loading in vivo. The loading parameters of a selection of cell and
tissue loading models are presented in Table 3. The use of scaf-
folds can impart some structure to the cells for culture-basedmodels,
and permit cyclic loading of isolated cells, albeit within ranges that
are governed by the strength of the matrix in which they are
embedded.
The heterogeneity of the cartilage structure means that precise
reconstruction of the tissue in vitromay not be possible, and so com-
promises must be made when constructing a load based model
(Gannon et al., 2012). The individual phenotype of each chondro-
cyte is related to their location in the tissue (Fujioka et al., 2013;
Schuurman et al., 2015) and therefore, in homogeneous tissue
models, chondrocytes may not behave in the same manner.
Future directions
The multifactorial nature of OA should be considered when de-
signing a model to reproduce this disease, even if it is only testing
a single parameter, such as the response to a load or catabolic stim-
ulus. A deeper understanding of the pathways evoked in in vitro
models, and their relevance to the changes seen in naturally-
occurring OA phenotypes, is important in order to improve the
translational relevance of the conclusions drawn.
To date, the vast majority of explant- and culture-based models
have assessed cartilage in isolation.Whilst this might reﬂect the ease
of manipulating cartilage and the resilience of chondrocytes in cell
culture, progress in tissue engineering and cell culture techniques
will allow for the development of more advanced models includ-
ing other cell types. The responsiveness of bone to stimuli and the
cross talk that occurs between the different tissues in OA joints
dictate that models should consider the role of multiple tissues when
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assessing the response to a given stimulus, so as to enable more
meaningful translation to the anticipated response in vivo.
There is no all-encompassingmodel that is suitable for all studies
of OA, and no single model can be used to perfectly simulate
naturally-occurring events. Whilst models seek to answer speciﬁc
biological questions, more standardised end-points for the molec-
ular and physiological parameters assessed are necessary, since at
present it is impossible to directly compare the outcomes of the
many in vitro OA models published in the scientiﬁc literature.
Other areas of articular health research, such as those looking
at histological assessments of cartilage repair and damage1 (Glasson
et al., 2010), have developed guidelines upon which assessments
should be made through the consensus of experts and the publi-
cation of their recommendations. In molecular biology, similar
guidelines have been developed for performingmicroarray and quan-
titative PCR studies (Brazma et al., 2001; Bustin et al., 2009). Whilst
the in vitro models of OA have many different functions and out-
comes, guidelines could still be developed to determine the
endpoints which are matrix- and chondro-protective, and the
minimumnumber of features of amodel (such asmeasures of matrix
release and turnover, transcription changes and/or cellular mor-
phometric changes) which are agreed to represent an ‘OA-like’
scenario. Similarly, models seeking to investigate the pathogen-
esis of OAmust justify the nature of stimulatory conditions, relative
to the in vivo disease, beyond simply that required to produce a re-
sponse. At the very least, in vitro models should be standardised
to a particular disease phenotype, with reasoning for the source of
the cells and/or tissues used and the outcomes to be measured, as
there is no single OA phenotype which can be encompassed by all
models.
Conclusions
The molecular pathways underpinning cytokine-stimulation and
load-based in vitro models of disease are similar. The combination
of different model types may permit the use of stimuli which are
physiologically relevant and which allow us to understand the de-
velopment and progression of the disease, particularly the early
phase, rather than simply the catastrophic downstream events after
it has begun. Standardisation of approaches, bothwithin and between
different species will allow the wider applicability of results between
studies, which in turn will enhance our understanding of the disease.
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